Abstract
The TGF-β signaling pathway plays a significant role in various biological phenomena such as cell growth, embryogenesis, differentiation, morphogenesis and apoptosis. Gastrointestinal endodermal stem cells, influenced by TGF- β signals, undergo asymmetric cell division that leads to differentiation into tissue-specific functional cells such as hepatocytes and gut epithelial cells. Disruption of this process results in tissue-specific cancer development. This review illustrates the role of TGF-β signaling in normal and cancer stem cells. Through mouse studies targeting different members of this pathway, investigators will be able to better define mechanisms of malignant progression in order to develop and improve cancer therapeutics.
Keywords: TGF-β, ELF, Smad4, gastrointestinal tract, cancer stem cells
Current Cancer Therapy Reviews
Title: TGF-β Signaling in Gastrointestinal Cancer Stem Cells
Volume: 4 Issue: 3
Author(s): Chohee Yun, Jonathan Mendelson, Young Woo Kim and Lopa Mishra
Affiliation:
Keywords: TGF-β, ELF, Smad4, gastrointestinal tract, cancer stem cells
Abstract: The TGF-β signaling pathway plays a significant role in various biological phenomena such as cell growth, embryogenesis, differentiation, morphogenesis and apoptosis. Gastrointestinal endodermal stem cells, influenced by TGF- β signals, undergo asymmetric cell division that leads to differentiation into tissue-specific functional cells such as hepatocytes and gut epithelial cells. Disruption of this process results in tissue-specific cancer development. This review illustrates the role of TGF-β signaling in normal and cancer stem cells. Through mouse studies targeting different members of this pathway, investigators will be able to better define mechanisms of malignant progression in order to develop and improve cancer therapeutics.
Export Options
About this article
Cite this article as:
Yun Chohee, Mendelson Jonathan, Kim Woo Young and Mishra Lopa, TGF-β Signaling in Gastrointestinal Cancer Stem Cells, Current Cancer Therapy Reviews 2008; 4 (3) . https://dx.doi.org/10.2174/157339408785294339
DOI https://dx.doi.org/10.2174/157339408785294339 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Why are Excipients Important to Neonates?
Current Pharmaceutical Design Nanosuspensions of Poorly Water Soluble Drugs Prepared by Top-down Technologies
Current Pharmaceutical Design Targeting the Immune System in Cancer
Current Pharmaceutical Biotechnology miRNAs in Insulin Resistance and Diabetes-Associated Pancreatic Cancer: The ‘Minute and Miracle’ Molecule Moving as a Monitor in the ‘Genomic Galaxy’
Current Drug Targets Beclin 1 Biology and its Role in Heart Disease
Current Cardiology Reviews Essential Role of Gli Proteins in Glioblastoma Multiforme
Current Protein & Peptide Science Targeting the EGF/HER Ligand-Receptor System in Cancer
Current Pharmaceutical Design Curcumin and its Formulations: Potential Anti-Cancer Agents
Anti-Cancer Agents in Medicinal Chemistry Challenges in the Design of Clinically Useful Brain-targeted Drug Nanocarriers
Current Medicinal Chemistry Germacrone: A Potent Secondary Metabolite with Therapeutic Potential in Metabolic Diseases, Cancer and Viral Infections
Current Drug Metabolism Current Development of Metal Complexes with Diamine Ligands as Potential Anticancer Agents
Current Medicinal Chemistry Application of dsRNA in Cancer Immunotherapy: Current Status and Future Trends
Anti-Cancer Agents in Medicinal Chemistry Immunomodulatory Lactoferrin in the Regulation of Apoptosis Modulatory Proteins in Cancer
Protein & Peptide Letters The Potential of Microalgae for the Production of Bioactive Molecules of Pharmaceutical Interest
Current Pharmaceutical Biotechnology Chelating Agents for Metal Intoxication
Current Medicinal Chemistry Non-Small Cell Lung Cancer: From Cytotoxic Systemic Chemotherapy to Molecularly Targeted Therapy
Current Medicinal Chemistry - Anti-Cancer Agents iNOS: A Potential Therapeutic Target for Malignant Glioma
Current Molecular Medicine Fibroblast Growth Factor-Inducible 14: Multiple Roles in Tumor Metastasis
Current Molecular Medicine Poly (ADP-Ribose) Polymerase-1 (PARP-1) as Immune Regulator
Endocrine, Metabolic & Immune Disorders - Drug Targets Preface
Current Pharmaceutical Design